Dyselectrolytemia in chronic obstructive pulmonary diseases with acute exacerbation
P Das1, M Bandyopadhay, K Baral
1Department of Physiology, Calcutta National Medical College, Kolkata, India. pdasmd@yahoo.in
Summary
Acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) is linked to lower serum sodium and potassium levels. Monitoring these electrolytes may help prevent fatal outcomes in COPD patients.
Area of Science:
- Pulmonary Medicine
- Clinical Biochemistry
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern.
- Acute exacerbations of COPD can lead to severe morbidity and mortality.
- Lack of awareness regarding prognostic predictors contributes to adverse outcomes.
Purpose of the Study:
- To investigate serum sodium and potassium levels in patients experiencing acute COPD exacerbations.
- To compare electrolyte levels in COPD patients with healthy controls.
- To identify potential markers for predicting fatal outcomes in acute COPD.
Main Methods:
- Cross-sectional study comparing acute COPD exacerbation patients and healthy controls.
- Measurement of serum sodium and potassium levels using standard laboratory techniques.
- Statistical analysis to determine significant differences between groups (p <0.05).
Main Results:
- Significantly lower serum sodium levels observed in acute COPD exacerbation patients (133±6.86 meq/L) compared to controls (142±2.28 meq/L).
- Significantly lower serum potassium levels observed in acute COPD exacerbation patients (3.39±0.96 meq/L) compared to controls (4.52±0.02 meq/L).
- Electrolyte derangement is a notable finding in acute COPD exacerbations.
Conclusions:
- Serum sodium and potassium levels are frequently deranged during acute COPD exacerbations.
- Routine monitoring of serum electrolytes is recommended for patients with acute COPD.
- Identifying and managing electrolyte imbalances may help reduce fatal outcomes in COPD.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: